Context-dependent rewiring of dual-function proteins in cancer: a sequential strategy to restore apoptosis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Resistance to programmed cell death (apoptosis) is a hallmark of cancer, hindering effective treatment.
• Key proteins like p53, Ras, and NF-κB regulate cell fate, but become deregulated by mutations and tumor microenvironment (TME) signals.
• Previous therapies often overlook crucial mechanisms, such as Ras-mediated suppression of p53, contributing to treatment failure.

Purpose of the Study:

• To critically analyze existing therapeutic approaches for overcoming cancer's resistance to apoptosis.
• To propose a novel, sequential therapeutic strategy for restoring cancer cells' apoptotic competence.
• To highlight the importance of addressing tumor microenvironment adaptations and oncogenic signaling pathways.

Main Methods:

• Review and critical analysis of previous therapeutic strategies targeting cancer cell death pathways.
• Identification and emphasis on overlooked mechanisms, including Ras-mediated p53 suppression.
• Proposal of a phased therapeutic approach integrating TME modulation, Ras inhibition, and p53 restoration.

Main Results:

• Dismantling TME adaptations (hypoxia, inflammation, autophagy) is proposed as the first step.
• Inhibiting oncogenic Ras signaling is the second critical step in the proposed strategy.
• Restoring p53 activity is the final step to re-sensitize cancer cells to apoptosis.

Conclusions:

• A sequential, phased therapeutic strategy offers a rational framework for overcoming resistance to programmed cell death in cancer.
• This approach integrates biomarker-guided patient stratification and considers tumor-microenvironment co-evolution.
• The proposed strategy provides a pathway for translational and clinical testing to improve cancer therapy outcomes.